Effects of Basic Body Awareness Therapy on Gait and Plantar Pressure in Healthy Young Adults
1 other identifier
interventional
33
1 country
1
Brief Summary
This interventional study will evaluate the effects of Basic Body Awareness Therapy (BBAT) on gait and plantar pressure outcomes in healthy young adults. Participants aged 18 to 25 years will receive a 12-week BBAT program delivered twice weekly by a physiotherapist trained in BBAT. Outcomes will be assessed at baseline, after the 12-week intervention, and at 3-month follow-up. The primary aim is to determine changes in gait speed and other spatiotemporal gait parameters during the 10-meter walk test. Secondary aims are to examine changes in static and dynamic plantar load distribution, right-left load sharing, and regional plantar pressure parameters. The study hypothesizes that BBAT will improve gait speed, reduce right-left differences in spatiotemporal gait parameters, improve bilateral load distribution during static stance and walking, and maintain these gains at 3-month follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2026
CompletedStudy Start
First participant enrolled
June 29, 2026
CompletedFirst Posted
Study publicly available on registry
July 7, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 4, 2027
July 15, 2026
July 1, 2026
3 months
June 26, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change in Gait Speed
Gait speed will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles. Participants will be instructed to walk at maximum walking speed on a 10-meter walkway. The best test performance will be used for analysis. The metric will be recorded in meters/second.
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Cadence
Cadence will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Cadence will be recorded as the number of steps per minute. Unit of Measure: steps/min
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Step Length
Step length will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Step length will be recorded in meters. Unit of Measure: m
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Step Time
Step time will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Step time will be recorded in seconds. Unit of Measure: s
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Stride Time
Stride time will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Stride time will be recorded in seconds. Unit of Measure: s
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Stance Phase Duration
Stance phase duration will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Stance phase duration will be recorded as a percentage of the gait cycle. Unit of Measure: %
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Swing Phase Duration
Swing phase duration will be assessed during the 10-meter walk test using Noraxon Ultium instrumented insoles and processed using MyoResearch 3.16. Swing phase duration will be recorded as a percentage of the gait cycle. Unit of Measure: %
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Gait Asymmetry Index
The asymmetry index for gait-phase timing parameters will be calculated using the formula: AI = \[(Right - Left) / ((Right + Left)/2)\] × 100 The asymmetry index will be expressed as a percentage, with higher values indicating greater gait asymmetry. Unit of Measure: %
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Secondary Outcomes (3)
Change in Static Plantar Load Distribution
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Change in Dynamic Plantar Pressure Distribution During Walking
Baseline, after 12 weeks of intervention, and 3 months after intervention completion.
Therapy Adherence
Throughout the 12-week intervention period.
Study Arms (1)
Experimental: Basic Body Awareness Therapy-BBAT Group
EXPERIMENTALParticipants will receive a 12-week BBAT program, two sessions per week, with each session lasting approximately 45-60 minutes. Sessions will be supervised by a physiotherapist trained in BBAT.
Interventions
The Basic Body Awareness Therapy program includes low-intensity physiotherapy exercises focused on awareness of contact with the floor, postural alignment, breathing-movement integration, weight transfer, trunk control, balance, and fluent movement quality.
Eligibility Criteria
You may qualify if:
- Aged 18 to 25 years
- Able to walk independently
- No history of lower-extremity, spine, or balance-affecting trauma and/or surgery within the last 6 months
- Not receiving regular Basic Body Awareness Therapy
- Provides written informed consent
You may not qualify if:
- History of neurological, vestibular, or rheumatological disease
- Acute musculoskeletal injury
- Serious visual or hearing impairment
- Pain, deformity, or assistive device use that may affect walking performance
- Participation in a physiotherapy program and/or regular exercise program within the last 6 months
- Any condition preventing regular participation in assessment or therapy sessions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hacettepe Universitylead
- Saglik Bilimleri Universitesicollaborator
Study Sites (1)
University of Health Sciences
Ankara, 06100, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Özge ÇANKAYA, PhD
Saglik Bilimleri Universitesi
- STUDY DIRECTOR
Nilufer Keskin Dilbay, PhD
Saglik Bilimleri Universitesi
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- No masking will be used because all participants receive the same behavioral physiotherapy intervention and assessments are performed within a single-group repeated-measures design.
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 26, 2026
First Posted
July 7, 2026
Study Start
June 29, 2026
Primary Completion (Estimated)
September 29, 2026
Study Completion (Estimated)
January 4, 2027
Last Updated
July 15, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share